ZOLPIDEM TARTRATE (Zolpidem Tartrate Extended-Release) Nursing Considerations

What is the generic name?

ZOLPIDEM TARTRATE

What is the Trade Name for ZOLPIDEM TARTRATE?

Zolpidem Tartrate Extended-Release

What are the Indications for ZOLPIDEM TARTRATE?

• 1 INDICATIONS AND USAGE Zolpidem Tartrate Extended-Release Tablets, USP, are indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance (as measured by wake time after sleep onset). The clinical trials performed in support of efficacy were up to 3 weeks (using polysomnography measurement up to 2 weeks in both adult and elderly patients) and 24 weeks (using patient-reported assessment in adult patients only) in duration [see CLINICAL STUDIES ( 14 ) ] . Zolpidem tartrate extended-release tablets, a gamma-aminobutyric acid (GABA) A receptor positive modulator, are indicated for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance. ( 1 )

References: https://open.fda.gov/